Dr SANTOSH H S

MBBS, MRCP (Int Med.), MRCP (D&E), CCST (D&E), FRCP (UK)

Consultant in Diabetes & Endocrinology

Doctor's Message 

Languages spoken 

Kannada, Telugu, Tamil, Hindi, English

Areas of Interest 

AGHD and Osteoporsis

Publications

1. Santosh HS, Barton J, Rees DA. Cushing's disease as the first endocrine manifestation in cousins with men 1: evidence for a genotype-phenotype correlation? SFE Regional clinical cases seminar. BES. 16th May 2013. Best Poster Prize. 2. Santosh HS, Rees DA. Hyperinsulinaemic hypoglycaemia but no pancreatic lesion. SFE Regional clinical cases seminar. BES. 16th May 2013. 3. Santosh HS, Udiawar M, & Bolusani, H. Pituitary tuberculosis. Endocrine abstracts. Society for Endocrinology, BES. Harrogate. 18th March 2013. 4. Udiawar M, Santosh HS, Bolusani H, Davies S, & Okosieme B. Tumours metastatic to the pituitary gland presenting with atypical symptoms. Society for Endocrinology, BES. Harrogate. 18th March 2013. 5. Santosh HS, Hamilton A, Ahluwalia R, Barraclough DL, Fraser WD, Vora JP. Cross-correlation of Circulating Sclerostin over 24 hours to PTH, Phosphate and Bone Markers in Healthy Young Men. European Congress of Endocrinology. Copenhagen. 27th Apr 2013. 10. Mon A, Sreemantula G, Santosh HS, Sharma D, Vora J. Diagnostic & Therapeutic Challenges in Patients with Cyclical Cushing�s Syndrome: A case series. Endo 2010 San Diego.19-22 Jun 2010. 12. Santosh HS, Dubey G, Biswas M. Statin therapy in Type 2 Diabetes � Prescribed but not optimised. WEDS 09 Celtic Manor Hotel. May 2009. 13. Santosh HS, Santosh D, Evans PJ. Metabolic Syndrome in Type 1 Diabetes Using IDF Guidelines. BES 09. Harrogate International Centre. Mar 2009. 14. Santosh HS, Black G, Swidan A, Platts JK, Hassanein MM, Wong SPY. A Complex case of Ketosis. Diabetes UK APC, Glasgow, SECC. Mar 2009. 15. Santosh HS, Dubey G, Biswas M. Statin therapy in Type 2 Diabetes � Prescribed but not optimised. Endo 08 San Francisco Jun 2008. 16. Santosh HS, Nair H. Advances in the management of stroke. Welsh Stroke Conference, Cwmbran, Nov 2001. 17. Peters A, Olateju T, Deschenes J, Shankarnarayan SH, Chua N, Shapiro AMJ, Senior P. Posttransplant Lymphoproliferative Disorder After Clinical Islet Transplantation: Report of the First Two Cases. Am J Transplant. 2017 Sep;17(9):2474-2480. doi: 10.1111/ajt.14303. Epub 2017 May 18. PMID: 28390107. 19. Udiawar M, Santosh HS, Bolusani, H, Davies S, & Okosieme B. Pituitary tuberculosis. Endocrine abstracts. Endocrine Abstracts (2013) 31; P102. 20. Santosh HS, Evans M, Vora JP. New and Future therapies in diabetes. Managing Diabetes. Springer Healthcare. 2011; 61-82. 21. Santosh HS, Evans M, Vora JP. Managing the Complications of Diabetes. Managing Diabetes. Springer Healthcare. 2011; 83-102. 22. Santosh HS, Vora JP. Incretins in the management of Diabetes. Treatment Strategies Diabetes. Cambridge Research Centre.2010;vol. 2(1);130-142. 23. Sreemantula G, Santosh HS, Vora JP. Pharmacotherapy in Type 2 Diabetes; clinical evidence. Type 2 Diabetes Second edition- Oxford Diabetes Library. 2010; 55-80. 24. Santosh HS, Santosh D, Evans PJ. Metabolic Syndrome in Type 1 Diabetes Using IDF Guidelines. Endocrine Abstracts (2009) 19; P153. 25. Santosh HS, Black G, Swidan A, Platts JK, Hassanein MM, Wong SPY. A Complex Case of Ketosis. Diabetes Medicine 2009 March; vol.26 suppl 1: 79-199 26. Santosh HS, Dubey G, Biswas M. Statin therapy in Type 2 Diabetes � Prescribed but not optimised. Endo Abstracts (2008), P2-335; 480.

Hobbies

Music, Badmiton